Clayton A. Smith

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

Daniel A. Pollyea, Brett M. Stevens, Courtney L. Jones et al. · Nature Medicine · 2018 · 768 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +9

Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells

Courtney L. Jones, Brett M. Stevens, Angelo D’Alessandro et al. · Cancer Cell · 2018 · 539 citations · Full text

Hematological Malignancy, Biochemistry, Medicine +5

Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity

Robert W. Storms, Aliana P. Trujillo, James B. Springer et al. · Proceedings of the National Academy of Sciences · 1999 · 534 citations

Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia

Shanshan Pei, Daniel A. Pollyea, Annika Gustafson et al. · Cancer Discovery · 2020 · 518 citations

Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +19

MIFlowCyt: The minimum information about a flow cytometry experiment

Jamie A. Lee, Josef Špidlen, Keith Boyce et al. · Cytometry Part A · 2008 · 494 citations · Full text